Vivani Medical, Inc.
NASDAQ:VANIMedical - Devices
+$0.02 today
- Market cap
- $94.71M
- Beta
- 3.29
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$0.33
Volume 0.18M
Average 0.24M
VANI Total Current Liabilities
All obligations due within one year.
Vivani Medical, Inc.NASDAQ: VANI
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 9.3% from a year ago
Total current liabilities stood at $6.78M at the end of Q1 FY2026, up 9.3% from a year earlier and up 2.6% from the prior quarter. Over 3 fiscal years it compounded at -1.1% a year.
Context
- Total current liabilities amounted to 16.0% of total assets at the end of Q1 FY2026, down 1.5 pp from a year earlier.
- Total current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +9.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 6.6M USD
- Year-over-year change
- +10.3%
- 4-year CAGR
- +33.4%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.6M | +10.3% |
| FY2024 | 2024-12-31 | 5.99M | +4.6% |
| FY2023 | 2023-12-31 | 5.72M | -16.1% |
| FY2022 | 2022-12-31 | 6.82M | +227.0% |
| FY2021 | 2021-12-31 | 2.09M | — |
Total Current Liabilities vs competitors
How VANI compares with its peers on the latest reported figures
- Peers report in different currencies, so total current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +9.3% is the 6th highest of 8, against a peer median of +27.3%.
- Total current liabilities amounts to 16.0% of total assets for VANI, versus a peer median of 7.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $66.67M USD | +190.4% | +80.3% | 129.3% | |
| Mar 2026 | $16.12M USD | +14.8% | +0.7% | 7.4% | |
| Mar 2026 | $10.56M USD | +92.3% | +49.2% | 3.9% | |
| Mar 2026 | $10.15M USD | +27.3% | +10.0% | 16.8% | |
| Mar 2026 | CA$7.15M CAD | -7.8% | -7.9% | 22.7% | |
| Mar 2026 | $6.78M USD | +9.3% | -1.1% | 16.0% | |
IMAImageneBio Inc | Mar 2026 | $6.63M USD | -24.6% | -19.5% | 4.9% |
| Mar 2026 | $3.39M USD | +78.9% | +18.2% | 4.3% | |
| Peer median (excluding VANI) | — | +27.3% | +10.0% | 7.4% | |
Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Vivani Medical, Inc.
NASDAQ:VANI
Intrinsic Alpha fair value
Locked
Current Price
$1.05
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.